SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as investors focus on the potential for a gamma squeeze driven by high call option interest and imminent data readouts from the AACR conference. The community remains deeply divided, with bulls highlighting the long survival tails in clinical trials as evidence of therapeutic success, while bears express skepticism regarding trial design consistency and regulatory approval hurdles.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is experiencing heightened investor activity driven by the U.S. government's recent mandates for space-based nuclear initiatives and ongoing optimism regarding micro-reactors to power AI data centers. While the community is actively debating the company's long-term commercialization timeline and regulatory hurdles, social sentiment remains a mix of intense retail speculation on short-term volatility and institutional interest in the broader nuclear energy thematic.

Daddy Darth Sidious

The community is actively discussing a potential market rotation from related tokens into SIDIOUS, with participants debating whether it represents a genuine opportunity or a speculative pump-and-dump scheme. Traders are focusing on social momentum and strategic entry points, aiming to capitalize on expected volatility leading into the weekend.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

Binance is trending as the exchange takes proactive measures against fraudulent activity, including offering a bounty to track down fake listing agents. Community sentiment remains focused on the exchange's security initiatives and the potential long-term price action of BNB.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is seeing increased investor attention as the community anticipates critical clinical data readouts and potential regulatory milestones. Shareholders are actively debating the company's valuation relative to recent industry acquisitions, focusing on the upcoming prostate cancer data as a primary catalyst for a long-awaited revaluation.

Daddy Darth Vader

The community is actively engaged in a rivalry known as the 'Daddy Wars' between $DARTH, $MAULCOIN, and the newly launched $SIDIOUS. Investors are debating the long-term viability of these meme tokens, with discussions heavily focused on liquidity management, the transparency of project developers, and strategic rotation between the competing assets.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is currently trending as a potential high-upside opportunity, with community members highlighting its ultra-low circulating supply and lack of future dilution as key catalysts for a parabolic move. Investors are actively debating its recovery potential against past performance, frequently comparing its tokenomics to larger market cap coins while emphasizing the need for increased volume to trigger a breakout.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is currently trending as investors focus on the commercial rollout of ZEVASKYN, with the community actively monitoring patient treatment milestones and the activation of new Qualified Treatment Centers. While short interest remains elevated, bulls are closely watching for signs of revenue ramp-up and profitability in early 2026 to validate the company's transition into a commercial-stage gene therapy provider.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The iShares 20+ Year Treasury Bond ETF (TLT) remains a focal point as investors grapple with escalating geopolitical instability in the Middle East and its potential inflationary impact on bond yields. The community is actively debating whether the current environment serves as a long-term capital preservation opportunity or a risky trap, while monitoring technical levels for signs of a squeeze.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is in the spotlight as investors digest recent financial results while anticipation builds for the CHOPIN trial data due in mid-October. Despite a strong underlying business, the stock faces volatility as the community debates the impact of pricing shifts, site expansion pacing, and the potential for the upcoming clinical data to catalyze a shift toward frontline use.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
